Recent Updates
Recently added Catalysts
DRTS Positive Sentiment Score: 60/100

Alpha Tau Medical to Present at the Emerging Growth Conference on August 9 th , 2023 JERUSALEM

Wednesday, August 2, 2023 1 min read
Key Takeaway: Alpha Tau Medical Ltd. announced that its CFO, Raphi Levy, will present at the Emerging Growth Conference on August 9th, 2023. The presentation will focus on the company's innovative cancer treatment technology, Alpha DaRT. This conference provides an opportunity for the company to engage with investors and increase awareness of its advancements in cancer therapy. An archived version of the presentation will be available for those unable to attend live.

Market Sentiment Analysis

POSITIVE FACTORS

  • Alpha Tau Medical is actively engaging with investors by presenting at a notable conference.
  • The company is showcasing its innovative alpha-radiation cancer therapy, Alpha DaRT.
  • The event allows for greater visibility and potential networking opportunities.

Full Press Release Details

Alpha Tau Medical to Present at the Emerging Growth
Conference on August 9th, 2023
JERUSALEM, August 02, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha
Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ,
today announced that Raphi Levy, Chief Financial Officer, will present at the Emerging Growth Conference on August 9th, 2023.
Please register here to ensure you
are able to attend the conference and receive any updates that are released.
https://goto.webcasts.com/starthere.jsp?ei=1603283&tp_key=7656c5070a&sti=drts
Event: Emerging Growth Conference
Date: Wednesday, August 9 th , 2023
Time: 11:25-11:55 a.m. ET
Location: Virtual
If attendees are not able to join the event live on the day of the
conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, http://www.YouTube.com/EmergingGrowthConference.
About Alpha Tau Medical, Ltd.
Founded in 2016, Alpha Tau is an Israeli
medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid
tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
Investor Relations Contact:

Frequently Asked Questions

When will Alpha Tau Medical present at the conference?

Alpha Tau Medical will present on August 9th, 2023.

Who is presenting for Alpha Tau Medical at the conference?

Raphi Levy, the Chief Financial Officer, will present.

What innovative therapy is Alpha Tau Medical developing?

They are developing the alpha-radiation cancer therapy, Alpha DaRT.

Where can I watch the conference if I miss it live?

An archived webcast will be available on EmergingGrowth.com and YouTube.

What is Alpha Tau Medical's focus since its founding?

The company focuses on the treatment of solid tumors using Alpha DaRT.

Tags: DRTS Viatris Investor Conferences Healthcare Alpha Tau Medical Alpha DaRT cancer therapy Emerging Growth Conference
Last updated: Aug 2, 2023